NewsBite

Pfizer

Advertisement
Pfizer chief executive Albert Bourla.

After Pfizer’s coronavirus boom, CEO in crosshairs over sales slump

It’s a sharp turn in fortune for Albert Bourla, who oversaw development and mass production of the novel RNA vaccine that helped get the pandemic under control and put the global economy back on track.

  • Daniel Gilbert

Latest

The cast of Men Up, L-R: Steffan Rhodri, Paul Rhys, Iwan Rheon, Mark Lewis Jones, Phaldut Sharma.

All rise for the incredible true story of Viagra’s first trials

In 1994, a group of Welshmen took part in a study for Viagra. But the little blue diamond was no magic pill.

  • Michael Lallo
Pfizer slashed its profit and sales forecast due to declining demand for its COVID shots and pills.

Pfizer’s $14 billion COVID sales warning sparks investor relief

The past few days have been a reckoning for Pfizer, the pharma giant that gained most from the pandemic and has seen the biggest blow from its decline as demand for COVID shots and pills declined.

  • Nacha Cattan
Toilet rolls and other basic items were stripped from Australian supermarkets in March 2020.

COVID broke our pandemic rule book. What should be in our next plan?

We can’t predict when the next pandemic will come, but there are things we can learn from the last one.

  • Aisha Dow
covid boosters

Four-fifths of Australian adults have failed to get a bivalent booster. Here’s why that is a problem

A new variant of COVID-19 is on the rise, and the bivalent booster offers better protection from it.

  • Angus Dalton
A test swab at a CDC COVID-19 variant testing site inside the airport in Los Angeles.

Health officials warn of new, highly mutated COVID strain

Not much is known about BA.2.86, which was first spotted by virus trackers earlier this week and has already been detected in four countries.

  • Madison Muller
Advertisement
All adult Australians who have not had a COVID-19 infection or vaccination in the last six months can get an extra booster shot later this month, regardless of how many vaccine doses they have previously received.

Fresh COVID-19 booster shot approved as 10m doses of new vaccine due to arrive

All adult Australians who have not had a COVID-19 infection or vaccination in the last six months can get an extra booster shot later this month.

  • Natassia Chrysanthos
An audit of government programs found $2.6 billion worth of COVID-related spending has to go back into the budget.

Pfizer loses $57 billion in value as COVID bonanza wanes

Shares of Pfizer suffered a double-digit monthly decline as investors anticipate a troubled path ahead for the pharma giant, which expects sales of its COVID vaccine to slump 64 per cent this year.

  • Nacha Cattan and Bre Bradham
Chinese hospitals are being filled with patients seeking treatment for COVID-19.

‘We can’t even protect ourselves’: Beijing hospital chaos as cases surge

“Too many patients who indeed need treatment have flooded in,” one nurse said in Beijing. “We feel helpless.”

  • Eryk Bagshaw
Technicians at work in a BioNTech lab in Germany.

mRNA giant wants changes to vaccine regulations to speed up new jabs

BioNTech is one of the world’s two leading mRNA companies, and it has just announced it will open a research and development hub in Melbourne.

  • Liam Mannix

Original URL: https://www.smh.com.au/topic/pfizer-inc-1nph